CAMCI: Advancing the Use of Computerized Screening in Healthcare

Study on an Investigational Computerized Cognitive Assessment Tool

Recruiting
60 years - 100 years
All
Phase N/A
1 Location

Brief description of study.

This study is being conducted to test a new screening tool to assess cognition. This new tool will replace paper and pencil testing.

Detailed description of study

We will recruit and test up to 200 unique participants to test the performance of the CAMCI in comparison with paper pencil neuropsychological tests and to assess participants experience with and perceptions about the validity of the CAMCI. Participants will be asked to participate in 1-3 test sessions (i.e., baseline and 0-2 follow-up test sessions) as determined by the specific aim in which they are enrolled. CAMCI is a computerized screening tool for the assessment of cognitive status.
Participants will be compensated for their participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: healthy
  • Age: 60 years - 100 years
  • Gender: All

Inclusion Criteria

Adequate visual and auditory acuity to allow neuropsychological testing

Able to read, write and understand study and test requirements

 

Exclusion Criteria

Any significant neurologic disease, such as multi-infarct dementia, Parkinson’s disease, epilepsy, stroke, multiple sclerosis or head trauma; history of major depression or other major psychiatric disorder, such as, schizophrenia and bipolar disorder

Updated on 19 Feb 2024. Study ID: 1710662771

This study investigates a computerized tool for assessing cognitive status. The purpose of this study is to compare this new tool with traditional paper and pencil tests to see how well it works and to understand participants' experiences with it. The study aims to recruit up to 200 participants to test this new method and gather their feedback.

Participants will be involved in 1 to 3 test sessions, which may include a baseline session and up to two follow-up sessions. During these sessions, participants will use the computerized tool, known as CAMCI, to assess their cognitive abilities. Participants will be compensated for their time and involvement.

  • Who can participate: Individuals who can see and hear well enough to complete neuropsychological testing and are able to read, write, and understand the study requirements are eligible. Those with significant neurological diseases or major psychiatric disorders are excluded.
  • Study details: Participants will take part in computerized testing sessions that assess cognitive abilities. The study will compare results from these sessions with traditional testing methods and gather feedback from participants on their experiences.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here